Griffith University

Bilal Zulfiqar

Name: Bilal Zulfiqar
Position: PhD Student
Research Area: Leishmaniasis
Qualifications: Pharm.D, M.Phil

Biography: Bilal completed his Doctor of Pharmacy (Pharm.D) degree with an academic distinction from Hamdard University, Pakistan in 2008. After working as a registered Pharmacist he joined Hamdard University where he taught courses such as Pharmaceutical Biotechnology and Pharmacology to undergraduate students. Funded by the Federal Ministry of Science and Technology, he completed his Masters of Philosophy (M.Phil) in Applied Bio-sciences with majors in Molecular Immunology from The National University of Sciences and Technology (NUST), Pakistan in 2011. His work was related to production of monoclonal antibodies against blood group antigens used for diagnostic purposes and molecular cloning and expression of antigen B of human ABO blood group system. He also participated in a project titled “Production of DNA vaccine against New Castle Disease by cloning and expression of fusion protein of Mesogenic and Velogenic strains of New Castle Disease Virus (NDV) from Pakistan”. Bilal moved to Australia to join the Discovery Biology Group as a PhD candidate. His main focus is the identification and biological characterization of novel pharmacologically active compounds against Leishmaniasis.

Discovery Biology:

Publications:

Zulfiqar B, Shelper TB and Avery VM. Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discovery Today. [Review] 2017 Jun 21 [Epub ahead of print] PMID: 28647378.

Awards:

Won 3rd Prize Oral Presentation at ASMR Queensland Postgraduate Student Conference held on 31st May in Brisbane, Australia.

Won the SLAS Best Academic Poster Award, at SLAS2017 International Conference and Exhibition, which was held in Washington DC Feb 4-8, 2017 (Screening and Lab Automation Conference).

Selected to represent Griffith University in this year’s International Student Research Forum (ISRF) hosted by University of Nebraska Medical Center (UNMV), Omaha Nebraska USA from 4th to 8th June 2017. Airfares, accommodation and meals are all provided.

Awarded a Griffith University International Experience Incentive Scheme (IEIS) Travel Grant for an overseas program at University of Antwerp, Belgium.

Received Tony. B travel award (all expenses paid) to present at the SLAS2017 International Conference and Exhibition scheduled held on February 4-8, 2017 in Washington, DC.

Awarded all-expense paid scholarship to attend Eskitis/SIMM Symposium 2016 held on 1 & 2 November, 2016 in Shanghai, China.

Received 2016 ASP student conference travel grant to attend “International Congress for Tropical Medicine and Malaria” from 18-22 September 2016 in Brisbane, Australia.

Awarded all-expense paid scholarship for the event “Sao Paulo School of Advanced Science on Neglected Diseases Drug Discovery–focus on Kinetoplastids (SPSAS-ND3)” taking place at The Brazilian Centre for Research in Energy and Materials (CNPEM), Campinas- Brazil, from June 14-24, 2015.

Griffith University International Postgraduate Research Scholarship [GUIPRS] (2014-2017).

Griffith University Postgraduate Research Scholarship [GUPRS] (2014-2017).

Conferences:

Zulfiqar, B; Shelper, T.B; Jones, A.J; Avery, V.M. ASMR Queensland Postgraduate Student Conference held on 31st May in Brisbane, Australia (Oral; June 2017).

Zulfiqar, B; Shelper, T.B; Jones, A.J; Avery, V.M. International Student Research Forum (ISRF) hosted by University of Nebraska Medical Center (UNMV), Omaha Nebraska USA from 4th to 8th June 2017 (Oral; June 2017).

Zulfiqar, B; Shelper, T.B; Jones, A.J; De Rycker, M; Maes, L; Freitas-Junior, L.H Avery, V.M. 6th World Congress on Leishmaniasis held in Toledo, Spain from 16th-20th May, 2017 (Poster; May 2017).

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. SLAS2017 6th annual international conference and exhibition from February 4-8, 2017 in Washington, DC. USA.

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. Brisbane Life Science ECR Symposium on Dec 2nd, 2016 Cube -QUT Gardens Point, Brisbane, Australia.

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. Eskitis/SIMM Symposium 2016 Shanghai, China (Oral; Nov 2016).

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. International Congress for Tropical Medicine and Malaria 2016, Brisbane, Australia (Oral; September 2016).

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. Eskitis Student Symposium 2016, Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Australia (Oral; April 2016).

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. Eskitis Student Symposium, Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Australia (Oral; March 2015).

Zulfiqar, B; Jones, A.J; Shelper, T.B; Avery, V.M. Sao Paulo School of Advanced Science on Neglected Diseases Drug Discovery–focus on Kinetoplastids (SPSAS-ND3), Brazilian Centre for Research in Energy and Materials (CNPEM), Campinas, Brazil (Poster; June 2015).

Other:

Publications:

Asghar, K., Farooq, A., Zulfiqar, B., & Rashid, M. U. (2017). Indoleamine 2, 3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma. World journal of gastroenterology, 23(13), 2286.

Zulfiqar, B., Mahroo, A., Nasir, K., Farooq, R. K., Jalal, N., Rashid, M. U., & Asghar, K. (2017). Nanomedicine and cancer immunotherapy: focus on indoleamine 2, 3-dioxygenase inhibitors. OncoTargets and therapy, 10, 463.

Asghar, K., Ashiq, M. T., Zulfiqar, B., Mahroo, A., Nasir, K., & Murad, S. Indoleamine 2, 3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis. Experimental and Therapeutic Medicine. 2014 Oct; [DOI: 10.3892/etm.2014.2146].

Qureshi AM, Nasir K, Mahrooh A, Zulfiqar B & Asghar K. Indoleamine 2, 3-dioxygenase: potential in cancer immunotherapy. A Journal of Science for Development. 2014: 33.

Zulfiqar,B., Shah,M.A.A., Asghar,K. Monospecific anti-B antibody and ABO blood group system. Lap Lambert Academic Publishing GmbH & CO. KG heinrich-bocking-str 6-8, 66121 Saarbrucken, Germany. (ISBN: 978-3-8473-7635-4)

Awards:

NUST/MoST Scholarship (2009-2011)

GenBank Submissions:

Newcastle Disease virus isolate AG01 Fusion (F) protein mRNA, partial CDS, (2012) Newcastle disease virus: detection and characterization by Ghafar,A., Asif,S., Zulfiqar,B., Shah,M.A.A., Asghar,K. and Ashraf,M. (NCBI Accession # JX088638)

Newcastle Disease virus isolate AG02 Fusion (F) protein mRNA, partial CDS, (2012) Newcastle disease virus: detection and characterization by Ghafar,A., Asif,S., Zulfiqar,B., Shah,M.A.A., Asghar,K. and Ashraf,M. (NCBI Accession # JX088639)

Newcastle Disease virus isolate rwp01 Fusion (F) protein mRNA, partial CDS, (2012) Newcastle disease virus: detection and characterization by Ghafar,A., Asif,S., Zulfiqar,B., Shah,M.A.A., Asghar,K. and Ashraf,M. (NCBI Accession # JX088637)

Homo sapiens B-Specific 1-3 Galactosyl-transferase variant1 (ABO) mRNA, complete cds, (2011) Cloning & Expression of Human ABO blood group gene by Zulfiqar,B., Afzaal,H., Ehsan,N., Raza,M.I., Ashiq,T., Asghar,K., Abdullah,M.A. and Qadri,I. (NCBI Accession # JN791441)

Hepatitis B virus isolate NCVI-5314 precore/core protein (C) and core protein (C) genes, complete cds, (2011), Mutations in precore/core gene of Hepatitis B virus: A molecular study from Pakistan by Raza,A., Mehmood,K,, Begum,F., Zulfiqar,B., Qureshi,A.M., Qureshi,S. and Qadri,I. (NCBI Accession # JN132130)